Sign in

CIK 0001750284

  • Non-accelerated filer
  • Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300409740
Phone
+1 415-651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 17 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-04 Mitchell Shawnte CHIEF LEGAL OFFICER Option exercise +25,000 $4.37 $109K 25,000
2026-03-04 Mitchell Shawnte CHIEF LEGAL OFFICER Sale −24,767 $24.25 $601K 233
2026-03-04 Mitchell Shawnte CHIEF LEGAL OFFICER Sale −233 $24.69 $6K 0
2026-03-04 Mitchell Shawnte CHIEF LEGAL OFFICER Option exercise · Stock Option (Right to Buy) −25,000 410,000
2026-03-03 Mitchell Shawnte CHIEF LEGAL OFFICER Option exercise +15,000 $4.37 $66K 15,000
2026-03-03 Mitchell Shawnte CHIEF LEGAL OFFICER Sale −15,000 $23.01 $345K 0
2026-03-03 Mitchell Shawnte CHIEF LEGAL OFFICER Option exercise · Stock Option (Right to Buy) −15,000 435,000
2026-02-02 Mitchell Shawnte CHIEF LEGAL OFFICER Grant or award · Stock Option (Right to Buy) +220,000 220,000
2026-02-02 Mitchell Shawnte CHIEF LEGAL OFFICER Grant or award · Performance Stock Options (Right to Buy) +56,250 56,250
2025-02-28 Mitchell Shawnte CHIEF LEGAL OFFICER Grant or award · Stock Option (Right to Buy) +450,000 450,000

Page 1 of 1 · 10 trades